Reuters logo
10 天前
BRIEF-Klaria signs development, license and supply agreement with Purdue Pharma (Canada)
2017年8月9日 / 下午1点29分 / 10 天前

BRIEF-Klaria signs development, license and supply agreement with Purdue Pharma (Canada)

Aug 9 (Reuters) - Klaria Pharma Holding Ab (Publ)

* Klaria signs exclusive development, license and supply agreement with purdue pharma (canada) for acute treatment of opioid overdose (kl-00514)

* Klaria pharma holding says purdue pharma (canada) will pay co combination of upfront, milestone, success-based payments plus a royalty on sales

* Klaria pharma holding -staged, success-based payments during development phase and registration and approval process will total approximately $2.3 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below